总时间（秒）：17.57
问答时间（秒）：17.50

```json
{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_000177435.4:c.355G>A",
          "cDNA Change": {
            "transcript": "NM_000177435.4",
            "ref": "G",
            "alt": "A",
            "position": "355"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "355"
          },
          "Description in input context": "This variant causes a change in the kinase domain of the LRRK2 protein."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0003938"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase Activity Assay",
      "Material used": {
        "Material Source": "Cell lysate",
        "Material Name": "HEK293 cells transfected with LRRK2-355G/A",
        "Description": "The experiment was conducted using the lysate from HEK293 cells transfected with the LRRK2-355G/A variant."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000177435.4:c.355G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased kinase activity",
          "Result Description": "The LRRK2-355G/A variant showed a 2-fold increase in kinase activity compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each reaction was performed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "A kinase-inactive mutant of LRRK2 was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to determine statistical significance."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within the range of wild-type LRRK2.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity significantly higher than that of wild-type LRRK2 (p < 0.05).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```